Understanding Neurodevelopmental Disorders Key Risk Factors Explained
- Recent research sheds new light on the complex web of risk factors contributing to neurodevelopmental disorders (NDDs) in children.
- The Epi-Phare study, which analyzed data from over 1.7 million children born in France between 2010 and 2014, found that certain prenatal and perinatal factors increased the likelihood...
- The study also identified risk factors more strongly associated with specific disorders.
Recent research sheds new light on the complex web of risk factors contributing to neurodevelopmental disorders (NDDs) in children. A large-scale French study, published by the Epi-Phare scientific interest group, has identified both shared and distinct prenatal and perinatal risk factors associated with autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and intellectual disability (ID). The findings underscore the importance of early intervention and informed parental guidance while highlighting gaps in current understanding.
Shared and Specific Risk Factors
The Epi-Phare study, which analyzed data from over 1.7 million children born in France between 2010 and 2014, found that certain prenatal and perinatal factors increased the likelihood of multiple NDDs. These shared risk factors included:

- Maternal infections during pregnancy
- Preterm birth (before 37 weeks of gestation)
- Low birth weight (under 2,500 grams)
- Maternal use of certain medications, including antiepileptics and antidepressants
- Gestational diabetes and hypertension
The study also identified risk factors more strongly associated with specific disorders. For example, maternal smoking during pregnancy was linked more closely to ADHD, while advanced paternal age (over 45 years) showed a stronger correlation with autism. These distinctions suggest that while some biological pathways may contribute broadly to neurodevelopmental challenges, others may influence particular conditions.
Parental Awareness and Early Intervention
Public health initiatives in France are increasingly focused on educating parents about NDDs. A recent event in Montbrison, organized by local health authorities, aimed to provide families with information on recognizing early signs of neurodevelopmental differences and accessing support services. According to Le Progrès, the session emphasized that early diagnosis and intervention can significantly improve long-term outcomes for children with NDDs.
Experts at the event highlighted that while some risk factors—such as genetic predisposition—cannot be modified, others, like maternal health during pregnancy, are within parental control. For instance, managing chronic conditions like diabetes and avoiding exposure to certain medications or infections may reduce the likelihood of neurodevelopmental challenges. However, the study authors caution that these associations do not imply direct causation, and further research is needed to clarify the underlying mechanisms.
Rising Diagnoses: Better Detection or Growing Prevalence?
The apparent increase in diagnoses of NDDs—particularly dyslexia, ADHD, and autism—has sparked debate among researchers and educators. A report by VousNousIls explores whether the rise reflects improved awareness and diagnostic practices or an actual increase in prevalence. While some experts attribute the trend to broader diagnostic criteria and greater societal recognition of neurodiversity, others point to environmental and biological factors that may be contributing to the shift.
The Epi-Phare study’s findings align with this discussion, suggesting that both biological and social factors play a role. For example, the study noted that children born to mothers with lower socioeconomic status were at higher risk for NDDs, potentially due to limited access to prenatal care or increased exposure to environmental stressors. However, the authors stress that socioeconomic status alone does not account for the full spectrum of risk, and genetic and epigenetic factors remain critical areas of investigation.
Gaps in Knowledge and Future Research
Despite advances in understanding NDDs, significant gaps remain. The Epi-Phare study highlights the need for longitudinal research to track how prenatal and perinatal factors interact with genetic predispositions over time. The study calls for more inclusive data collection, particularly regarding underrepresented populations, to ensure that findings are applicable across diverse communities.
Another area of uncertainty is the role of environmental toxins, such as air pollution and endocrine-disrupting chemicals, in neurodevelopment. While some studies have suggested links between these exposures and NDDs, the evidence is not yet conclusive. The Epi-Phare researchers recommend further investigation into these potential risk factors, as well as the development of public health policies to minimize harmful exposures during pregnancy.
Implications for Public Health and Policy
The study’s findings have implications for both clinical practice and public health policy. For healthcare providers, the results underscore the importance of comprehensive prenatal care, including screening for infections, managing chronic conditions, and counseling expectant parents on medication use. Early intervention programs, such as speech therapy and behavioral support, are also critical for children showing signs of NDDs.

From a policy perspective, the study supports efforts to reduce disparities in access to prenatal care and early childhood services. In France, initiatives like the “Stratégie Nationale pour l’Autisme” aim to improve early detection and support for children with NDDs, but challenges remain in ensuring equitable access across regions and socioeconomic groups. The Epi-Phare study’s authors advocate for policies that address both biological and social determinants of neurodevelopmental health.
Parental Guidance and Support
For parents, the study offers both reassurance and actionable insights. While some risk factors for NDDs are beyond individual control, others—such as maintaining a healthy pregnancy, avoiding harmful substances, and seeking early medical advice—can be managed. Health authorities in France are increasingly providing resources to help parents navigate these challenges, including informational campaigns and community-based support groups.
As Pourquoi Docteur notes, the conversation around NDDs is evolving from one of stigma to one of understanding and inclusion. By equipping parents with accurate information and access to early intervention, health systems can help children with neurodevelopmental differences thrive. However, the study’s authors caution that much work remains to be done, particularly in translating research findings into practical, accessible support for families.
The Epi-Phare study represents a significant step forward in identifying the multifactorial nature of NDDs. While the findings provide valuable insights, they also highlight the need for continued research, public health investment, and societal awareness to address the complex challenges posed by these disorders.
